What is the share price of Jeena Sikho Lifecare Ltd (JSLL) today?
The share price of JSLL as on 18th September 2026 is ₹510.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Jeena Sikho Lifecare Ltd (JSLL) share?
The past returns of Jeena Sikho Lifecare Ltd (JSLL) share are- Past 1 week: -0.75%
- Past 1 month: -0.33%
- Past 3 months: -7.11%
- Past 6 months: -18.71%
- Past 1 year: -37.84%
- Past 3 years: 343.44%
- Past 5 years: 2550.05%
What are the peers or stocks similar to Jeena Sikho Lifecare Ltd (JSLL)?
The peers or stocks similar to Jeena Sikho Lifecare Ltd (JSLL) include:What is the dividend yield % of Jeena Sikho Lifecare Ltd (JSLL) share?
The current dividend yield of Jeena Sikho Lifecare Ltd (JSLL) is 0.88.What is the market cap of Jeena Sikho Lifecare Ltd (JSLL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jeena Sikho Lifecare Ltd (JSLL) is ₹6344.31 Cr as of 18th September 2026.What is the 52 week high and low of Jeena Sikho Lifecare Ltd (JSLL) share?
The 52-week high of Jeena Sikho Lifecare Ltd (JSLL) is ₹849.50 and the 52-week low is ₹485.10.What is the PE and PB ratio of Jeena Sikho Lifecare Ltd (JSLL) stock?
The P/E (price-to-earnings) ratio of Jeena Sikho Lifecare Ltd (JSLL) is 28.62. The P/B (price-to-book) ratio is 13.59.Which sector does Jeena Sikho Lifecare Ltd (JSLL) belong to?
Jeena Sikho Lifecare Ltd (JSLL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Jeena Sikho Lifecare Ltd (JSLL) shares?
You can directly buy Jeena Sikho Lifecare Ltd (JSLL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Jeena Sikho Lifecare Ltd
JSLL Share Price
NSEJSLL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JSLL Performance & Key Metrics
JSLL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 26.83 | 13.59 | 0.88% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
JSLL Company Profile
Jeena Sikho Lifecare is engaged in developing health care products and providing ayurvedic healthcare services in India.
JSLL Sentiment Analysis
JSLL Sentiment Analysis
JSLL Stock Summary · August 2026
Management described a quarter of strong profitability alongside continued investment in a long-term preventive healthcare buildout. Revenue from operations was INR 224 crore in Q1 FY27, while EBITDA reached INR 92 crore and PAT was INR 65 crore, with a 41% EBITDA margin and 28% PAT margin underscoring the scalability it sees in the model. At the same time, management said the business should be judged on its multi-year trajectory rather than any single quarter, as patient count and volume rose 10% sequentially, day-care volume increased from 16,000 to 19,000, and consultation growth signaled a larger funnel that should convert over time. It framed the strategy around keeping patients engaged across awareness, consultation, lifestyle support, services and products, with a 50-50 balance between services and products and a deliberate shift toward a more cash-rich mix after reducing government business. Management also pointed to 47% growth in Ayurveda products and 13% growth in Panchakarma, while noting about INR 6.5 crore of incremental spending on marketing, software and governance. Near term, it expects more beds, rising day-care activity, and continued growth in private business and OTC distribution.
JSLL Stock Growth Drivers
JSLL Stock Growth Drivers
10Strong Profitability and Scalable FY27 Growth
The company delivered a strong start to FY27, with Q1 revenue from operations of INR
Preventive Healthcare Ecosystem With Recurring Engagement
The company is building a prevention-led healthcare platform that connects awareness, health camps, consultations, OPD,
JSLL Stock Challenges
JSLL Stock Challenges
6Elevated operating costs from governance, technology, marketing, and wage-law changes
The quarter reflected a clear step-up in operating expenses driven by multiple one-time or above-normal
Weak economics of offline OTC expansion
The company’s OTC strategy faces unfavorable channel economics in physical retail. Management acknowledged that medical
JSLL Forecast
JSLL Forecasts
Price
Revenue
Earnings
JSLL Share Price Forecast
JSLL Share Price Forecast
All values in ₹
All values in ₹
JSLL Company Revenue Forecast
JSLL Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
JSLL Stock EPS (Earnings Per Share) Forecast
JSLL Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
JSLL
JSLL
Income
Balance Sheet
Cash Flow
JSLL Income Statement
JSLL Income Statement
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 102.67 | 117.54 | 116.08 | 139.52 | 175.35 | 191.29 | 224.25 | 218.97 | 238.73 | |||||||||
| Operating & Other expenses | 75.09 | 73.82 | 86.08 | 93.48 | 95.53 | 97.82 | 120.96 | 137.63 | 132.34 | |||||||||
| EBITDA | 27.58 | 43.72 | 30.00 | 46.04 | 79.82 | 93.47 | 103.29 | 81.34 | 106.39 | |||||||||
| Depreciation/Amortization | 5.36 | 6.25 | 8.47 | 9.03 | 9.65 | 10.40 | 11.26 | 16.38 | 15.39 | |||||||||
| PBIT | 22.22 | 37.47 | 21.53 | 37.01 | 70.17 | 83.07 | 92.03 | 64.96 | 91.00 | |||||||||
| Interest & Other Items | 1.70 | 2.07 | 3.79 | 3.10 | 1.66 | 4.35 | 3.10 | 3.73 | 3.47 | |||||||||
| PBT | 20.52 | 35.40 | 17.74 | 33.91 | 68.51 | 78.72 | 88.93 | 61.23 | 87.53 | |||||||||
| Taxes & Other Items | 4.79 | 8.81 | 4.53 | 8.58 | 17.22 | 19.97 | 22.27 | 16.09 | 21.58 | |||||||||
| Net Income | 15.73 | 26.59 | 13.21 | 25.33 | 51.29 | 58.75 | 66.66 | 45.14 | 65.95 | |||||||||
| EPS | 0.25 | 0.43 | 0.21 | 0.41 | 4.12 | 4.73 | 5.36 | 3.63 | 5.30 |
JSLL Company Updates
Investor Presentation
JSLL Stock Peers
JSLL Past Performance & Peer Comparison
JSLL Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Jeena Sikho Lifecare Ltd | 28.62 | 13.59 | 0.88% |
| Sun Pharmaceutical Industries Ltd | 38.40 | 5.26 | 0.87% |
| Torrent Pharmaceuticals Ltd | 85.10 | 10.47 | 0.70% |
| Zydus Lifesciences Ltd | 22.96 | 3.91 | 0.09% |
JSLL Stock Price Comparison
Compare JSLL with any stock or ETFJSLL Holdings
JSLL Shareholdings
JSLL Promoter Holdings Trend
JSLL Promoter Holdings Trend
JSLL Institutional Holdings Trend
JSLL Institutional Holdings Trend
In last 3 months, retail holding in the company has increased by 2.76%
In last 3 months, foreign institutional holding of the company has decreased by 1.38%
JSLL Shareholding Pattern
JSLL Shareholding Pattern
JSLL Shareholding History
JSLL Shareholding History
Mutual Funds Invested in JSLL
Mutual Funds Invested in JSLL
No mutual funds holding trends are available
Top 5 Mutual Funds holding Jeena Sikho Lifecare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0905% | Percentage of the fund’s portfolio invested in the stock 0.24% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 116/256 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0007% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 684/755 (-24) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 667/756 (-33) |
Compare 3-month MF holding change on Screener
smallcases containing JSLL stock
smallcases containing JSLL stock
Looks like this stock is not in any smallcase yet.
JSLL Events
JSLL Events
JSLL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
JSLL Dividend Trend
No dividend trend available
JSLL Upcoming Dividends
JSLL Upcoming Dividends
Cash Dividend
Ex DateEx DateSep 21, 2026
Dividend/Share
₹4.50
Ex DateEx Date
Sep 21, 2026
JSLL Past Dividends
JSLL Past Dividends
Cash Dividend
Ex DateEx DateSep 22, 2025
Dividend/Share
₹1.10
Ex DateEx Date
Sep 22, 2025
Cash Dividend
Ex DateEx DateAug 20, 2024
Dividend/Share
₹4.18
Ex DateEx Date
Aug 20, 2024
Cash Dividend
Ex DateEx DateAug 25, 2023
Dividend/Share
₹2.00
Ex DateEx Date
Aug 25, 2023
JSLL Stock News & Opinions
JSLL Stock News & Opinions
Jeena Sikho Lifecare Ltd share price slipped 1.20% to Rs 597.05. The Company's net profit soared by 46.16% to Rs 65.89 crore, while revenue from operations slightly gained 4.11% to Rs 224.4 crore in Q2FY26 over Q1FY26. The market capitalization of Wellness industry group stocks on BSE stood at Rs 9551.42 crore, tanking 25.17%. It has improved by 2.82% over last one week and collapsed sharply by 17.88% in last one month while the market capitalization of Jeena Sikho Lifecare Ltd has marginally improved by 3.06% and 19.10% in the same period respectively. Profit before tax (PBT) of Jeena Sikho Lifecare Ltd stood at Rs 87.53 crore in Q2 FY26, rallying 27.76% year-on-year, and jumping 42.95% quarter-on-quarter. EBITDA came in at Rs 78 crore, easing 0.08% YoY and gaining 4.35% sequentially. Total expenses softened by 4.08% to Rs 147.73 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 44.18 crore, seeing a marginal contraction of 3.94% YoY. For the TTM ended FY26, revenue from operations jumped by 39.71% to Rs 204.75 crore, while net profit surged by 199.55% to Rs 33.52 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 1545% to Rs 43.0 crore, and PBT surged 193.51% to Rs 44.29 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.52 crore in FY26, as against Rs 16.35 crore in FY25. Jeena Sikho Lifecare Ltd rallied 11.24% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.63% during the same period.
Jeena Sikho Lifecare Ltd share price declined by 1.20% to Rs 597.05. The Company's net profit surged by 46.16% to Rs 65.89 crore, while revenue from operations improved marginally 4.11% to Rs 224.4 crore in Q2FY26 over Q1FY26. The market capitalization of Wellness industry group stocks on BSE stood at Rs 9699.43 crore, tumbling by 25.17%. It has marginally improved by 1.60% over last one week and crashed 19.14% in last one month while the market capitalization of Jeena Sikho Lifecare Ltd has inched up 1.77% and 20.13% in the same period respectively. Profit before tax (PBT) of Jeena Sikho Lifecare Ltd stood at Rs 87.53 crore in Q2 FY26, rallying 27.76% year-on-year, and jumping 42.95% quarter-on-quarter. EBITDA came in at Rs 78 crore, rising 0.08% YoY and gaining 4.35% sequentially. Total expenses slightly declined by 4.08% to Rs 147.73 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 44.18 crore, seeing a marginal contraction of 3.94% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 39.71% to Rs 204.75 crore, while net profit saw a strong growth of 199.55% to Rs 33.52 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 1545% to Rs 43.0 crore, and PBT witnessed a strong rise of 193.51% to Rs 44.29 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 14.52 crore in FY26, as against Rs 16.35 crore in FY25. Jeena Sikho Lifecare Ltd jumped 11.24% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.63% during the same period.
Thacker & Company Ltd, HLE Glascoat Ltd, SKM Egg Products Export (India) Ltd and HCL Infosystems Ltd are among the other gainers in the BSE's 'B' group today, 02 June 2026.Jeena Sikho Lifecare Ltd surged 16.35% to Rs 573.1 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 11.14 lakh shares were traded on the counter so far as against the average daily volumes of 46082 shares in the past one month. Thacker & Company Ltd soared 15.21% to Rs 1440.1. The stock was the second biggest gainer in 'B' group. On the BSE, 347 shares were traded on the counter so far as against the average daily volumes of 23 shares in the past one month. HLE Glascoat Ltd spiked 13.27% to Rs 362. The stock was the third biggest gainer in 'B' group. On the BSE, 51173 shares were traded on the counter so far as against the average daily volumes of 8835 shares in the past one month. SKM Egg Products Export (India) Ltd jumped 13.04% to Rs 233.15. The stock was the fourth biggest gainer in 'B' group. On the BSE, 3.72 lakh shares were traded on the counter so far as against the average daily volumes of 74654 shares in the past one month. HCL Infosystems Ltd advanced 12.45% to Rs 13.64. The stock was the fifth biggest gainer in 'B' group. On the BSE, 2.58 lakh shares were traded on the counter so far as against the average daily volumes of 58502 shares in the past one month. Powered by Capital Market - Live
Arihant Foundations & Housing Ltd, Coastal Corporation Ltd, Birla Precision Technologies Ltd and RPP Infra Projects Ltd are among the other losers in the BSE's 'B' group today, 01 June 2026.Jeena Sikho Lifecare Ltd crashed 20.00% to Rs 491.95 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 2.95 lakh shares were traded on the counter so far as against the average daily volumes of 31843 shares in the past one month.Arihant Foundations & Housing Ltd lost 19.45% to Rs 735.55. The stock was the second biggest loser in 'B' group.On the BSE, 8628 shares were traded on the counter so far as against the average daily volumes of 4419 shares in the past one month.Coastal Corporation Ltd tumbled 17.77% to Rs 49.78. The stock was the third biggest loser in 'B' group.On the BSE, 31753 shares were traded on the counter so far as against the average daily volumes of 12772 shares in the past one month.Birla Precision Technologies Ltd shed 16.05% to Rs 38.91. The stock was the fourth biggest loser in 'B' group.On the BSE, 1.18 lakh shares were traded on the counter so far as against the average daily volumes of 68697 shares in the past one month.RPP Infra Projects Ltd dropped 14.21% to Rs 64.66. The stock was the fifth biggest loser in 'B' group.On the BSE, 17874 shares were traded on the counter so far as against the average daily volumes of 5902 shares in the past one month.Powered by Capital Market - Live
Jeena Sikho Lifecare announced that the Board of Directors of the Company at its meeting held on 30 May 2026, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 225%) , subject to the approval of the shareholders.
Net profit of Jeena Sikho Lifecare rose 78.10% to Rs 45.13 crore in the quarter ended March 2026 as against Rs 25.34 crore during the previous quarter ended March 2025. Sales rose 54.79% to Rs 215.55 crore in the quarter ended March 2026 as against Rs 139.25 crore during the previous quarter ended March 2025. For the full year,net profit rose 177.52% to Rs 221.85 crore in the year ended March 2026 as against Rs 79.94 crore during the previous year ended March 2025. Sales rose 70.84% to Rs 801.36 crore in the year ended March 2026 as against Rs 469.07 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales215.55139.25 55 801.36469.07 71 OPM %36.1532.87 -43.6029.97 - PBDT77.6142.94 81 345.09136.68 152 PBT61.2333.92 81 297.39107.58 176 NP45.1325.34 78 221.8579.94 178 Powered by Capital Market - Live
Jeena Sikho Lifecare will hold a meeting of the Board of Directors of the Company on 30 May 2026.
Jeena Sikho Lifecare has been awarded the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its Noida Hospital.
Jeena Sikho Lifecare has been awarded the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its Dehradun Hospital. The receipt of this NABH accreditation signifies adherence to nationally recognized standards for quality healthcare delivery, patient safety, and operational excellence. This development has occurred in the ordinary course of business and does not constitute business expansion, capacity enhancement, or acquisition.Powered by Capital Market - Live
Net profit of Jeena Sikho Lifecare rose 405.15% to Rs 66.73 crore in the quarter ended December 2025 as against Rs 13.21 crore during the previous quarter ended December 2024. Sales rose 91.60% to Rs 221.66 crore in the quarter ended December 2025 as against Rs 115.69 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales221.66115.69 92 OPM %45.4825.59 - PBDT100.2726.21 283 PBT89.0617.74 402 NP66.7313.21 405 Powered by Capital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant